首页> 美国卫生研究院文献>other >Atorvastatin prevents hypoxia-induced inhibition of endothelial nitric oxide synthase expression but does not affect heme oxygenase-1 in human microvascular endothelial cells
【2h】

Atorvastatin prevents hypoxia-induced inhibition of endothelial nitric oxide synthase expression but does not affect heme oxygenase-1 in human microvascular endothelial cells

机译:阿托伐他汀防止缺氧诱导的内皮一氧化氮合酶表达抑制但不影响人微血管内皮细胞中的血红素加氧酶-1

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Beneficial cardiovascular effects of statins, the inhibitors of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase, are particularly assigned to the modulation of inflammation. Endothelial nitric oxide synthase (eNOS) and heme oxygenase-1 (HO-1) are listed among the crucial protective, anti-inflammatory genes in the vasculature. Here we show that atorvastatin at pharmacologically relevant concentration (0.1 μM) enhanced the expression of eNOS in human microvascular endothelial cells (HMEC-1). Moreover, atorvastatin prevented hypoxia-induced decrease in eNOS expression. However, in the same cells atorvastatin was ineffective in modulation of HO-1 protein level. Therefore, we suggest that the protective effect of statins at their pharmacological concentrations is not mediated by enhancement of HO-1 activity, but may involve eNOS.
机译:他汀类药物(3-羟基-3-甲基戊二酰辅酶A(HMG-CoA)还原酶的抑制剂)的有益心血管作用尤其与炎症的调节有关。血管内皮一氧化氮合酶(eNOS)和血红素加氧酶-1(HO-1)被列为重要的保护性抗炎基因。在这里,我们显示在药理学相关浓度(0.1μM)的阿托伐他汀可增强人微血管内皮细胞(HMEC-1)中eNOS的表达。此外,阿托伐他汀可防止缺氧引起的eNOS表达下降。但是,在同一细胞中,阿托伐他汀在调节HO-1蛋白水平方面无效。因此,我们认为他汀类药物在其药理浓度下的保护作用不是通过HO-1活性的增强来介导,而是可能涉及eNOS。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号